Chemists
Also called Research chemist, Analytical chemist, Organic chemist, Synthetic chemist, Medicinal chemist
In brief
In May 2025, BLS counted 82,770 US chemists, with median pay of $91,240 a year. Of the BLS counts since 2003, the highest was 87,560, in May 2013. The earliest figure here is a Census count of 9,000 from 1900, not measured the same way as today's count. The last full technology era for chemists: Electronic lab notebooks, 2015 to 2022.
What the sources say
Official outlook
BLS projects employment to grow 6.4% from 2025 to 2035.
AI exposure studies
- 40% of this job's tasks are exposed to large language models. Not a forecast of job losses. Eloundou and others, 2023
- 0.1 estimated probability that the whole occupation could be computerised, over an unspecified number of years. Not a forecast of job losses. Frey and Osborne, 2013
Since the 2013 prediction
In 2013, Frey and Osborne put this job's probability of computerisation at 0.1. BLS counted 87,560 of these jobs in May 2013 and 82,770 in May 2025 (-5%, a change derived by Future History).
Data as of BLS OEWS May 2025; BLS Employment Projections 2025-35. BLS publishes these counts as yearly survey snapshots and cautions against reading them as a precise trend. In May 2021 BLS changed how it estimates these counts (a model-based method using three years of survey data) and moved fully to the 2018 occupation codes, so part of a change across 2021 can come from the method rather than the work.
Last updated .
Cite this page
Future History. (2026, October 11). Chemists: jobs and pay since 1900 [Data set; data as of BLS OEWS May 2025; BLS Employment Projections 2025-35]. https://futurehistory.earth/timeline/19-2031
Future History. "Chemists: jobs and pay since 1900." Data as of BLS OEWS May 2025; BLS Employment Projections 2025-35. Last modified October 11, 2026. https://futurehistory.earth/timeline/19-2031.
@misc{futurehistory_19_2031, author = {{Future History}}, title = {Chemists: jobs and pay since 1900}, year = {2026}, month = oct, howpublished = {\url{https://futurehistory.earth/timeline/19-2031}}, note = {Last updated 2026-10-11. Data as of BLS OEWS May 2025; BLS Employment Projections 2025-35}, }
The access date is today's date on your device.
≈ $88,901 in 2024 prices (derived by us, CPI-adjusted)
April 6, 1876: thirty-five chemists meet at the College of Pharmacy of the City of New York to found the American Chemical Society. John William Draper is elected first president and delivers his inaugural address at Chickering Hall in New York. The founders aim to stimulate original research, develop chemical talent across the United States, and raise public appreciation of the science. JACS (Journal of the American Chemical Society) begins publication in April 1879. ACS membership grows from 35 in 1876 to over 1,700 by 1900 and 63,000 by 1950. The founding marks the formal recognition of chemistry as a distinct professional occupation in the United States, separate from pharmacy, medicine, and natural philosophy.
World War I transforms the American chemical industry and the chemist workforce in a single year. German imports of coal-tar dyes, pharmaceuticals, and chemical intermediates had supplied most of the US market before the war; the British naval blockade of Germany and US entry in April 1917 cut that supply entirely. The US government subsidizes rapid construction of synthetic chemistry capacity, and over 1,700 chemists serve in the Chemical Warfare Service alone. The Haber-Bosch nitrogen fixation process, licensed from Germany under wartime seizure, anchors an American ammonia and explosives industry that will anchor agrochemical production for the next century. The crisis permanently establishes the strategic importance of a domestic professional chemist workforce.
At least 1,000 chemists are engaged in the wartime penicillin program -- the largest coordinated synthetic and fermentation chemistry effort in history to that date. Overcoming the hurdles to industrial-scale aerobic fermentation and sterile product isolation required close collaboration between organic chemists, biochemists, microbiologists, and chemical engineers. The program revolutionizes pharmaceutical manufacturing processes and establishes the pattern for the post-war pharmaceutical industry: large research chemistry teams, rigorous analytical QC, and regulatory documentation of manufacturing procedures. Simultaneously, DuPont chemists are scaling nylon for parachute production and Goodrich chemists are scaling synthetic rubber (GRS) under government coordination -- another 1,000+ chemists mobilized for a single program.
Archer J. P. Martin and Richard Synge receive the Nobel Prize in Chemistry for their invention of partition chromatography -- the foundation of modern gas chromatography and liquid chromatography. Their work, done in 1941-1943, is commercialized by Perkin-Elmer and A. J. P. Martin himself through the 1950s. By 1958, the flame ionization detector (FID) makes GC quantitative for most organic compounds. By 1965, GC-MS is commercially available. These instruments collectively transform analytical chemistry: structure determination that required days of classic wet chemistry now takes hours of spectral interpretation. Chemists shift from routine analysis toward interpretation, method development, and scientific judgment.
The ACS ChemCensus surveys approximately 85,000-90,000 employed chemists in the US mid-decade. In 1985 alone, 42,613 ACS members complete the ChemCensus survey. The mid-1980s represent near-peak employment in central industrial chemistry research labs -- DuPont Central Research, Dow's core R&D, Standard Oil Research, and the Bell Labs chemistry group are at or near their largest staffing. The second half of the 1980s will bring significant contraction as major chemical companies restructure, pharmaceutical mergers consolidate R&D organizations, and routine analytical QC is increasingly automated or outsourced.
USPTO Director Kathi Vidal issues formal inventorship guidance in February 2024: AI systems cannot be named patent inventors under US law; only natural persons who genuinely conceived the claimed invention qualify. This ruling has direct implications for chemist employment: the intellectual contribution of compound design, synthesis route conception, and property-prediction interpretation must be human-attributed, regardless of how much AI assistance was used. At the same moment, ACS issues AI authorship policy requiring disclosure of generative AI tool use in manuscripts while placing full accountability for accuracy on named human authors. The dual anchoring of patent inventorship and scientific authorship in human accountability reinforces the irreplaceable role of the practicing chemist even as AI tools handle more of the computational work.
Will AI replace chemists? What the research says
Each figure is stated by the named source; we publish no forecasts of our own. Where sources disagree, we show the disagreement rather than an average.
Each figure is stated by the named source; we publish no forecasts of our own. Where sources disagree, the spread is the honest signal.
What's changing day to day for chemists
Three parts of your work where AI is already doing real lifting, and what stays yours.
AI is sitting alongside you hereConduct literature triage and reaction-precedent review before a synthetic campaign: using Elicit and Reaxys to query the primary literature for reported preparations of target compound classes, reaction condition optimizations, and functional-group compatibility data
Conduct literature triage and reaction-precedent review before a synthetic campaign: using Elicit and Reaxys to query the primary literature for reported preparations of target compound classes, reaction condition optimizations, and functional-group compatibility data; identifying key safety incidents, yield limitations, and scalability constraints from published precedents; summarizing literature findings to inform route selection and experimental design before committing to bench work.[15],[1],[16]
Elicit and Reaxys AI compress literature synthesis from days to hours, but AI-generated reaction summaries can miss substrate-specific exceptions, misattribute conditions from one substrate class to another, or omit safety incidents that appear only in supplementary information or patent examples. Maintain a discipline of reading the primary source for any reaction type you have not personally run before, especially for exothermic reactions, reactions with highly reactive intermediates, or large-scale preparations where the safety profile at scale differs from small-scale lab conditions.
AI is sitting alongside you hereIdentify and triage candidate molecules for a medicinal chemistry or materials project using Schrödinger AI, running Glide docking against an AI-predicted or experimentally determined protein binding site to rank virtual compound libraries by predicted binding affinity
Identify and triage candidate molecules for a medicinal chemistry or materials project using Schrödinger AI, running Glide docking against an AI-predicted or experimentally determined protein binding site to rank virtual compound libraries by predicted binding affinity; applying FEP+ free energy perturbation to prioritize the top-ranked compounds by predicted relative solubility and selectivity; filtering for ADMET liabilities (predicted metabolic stability, permeability, hERG risk) before committing any candidate to bench-scale synthesis.[5],[6],[13]
Schrödinger FEP+ predictions provide high-value rank-ordering but carry force-field-dependent uncertainty that is largest for highly flexible, highly polar, or strongly ionizable molecules: common in drug-like compounds. Before using FEP+ predictions to eliminate candidates without experimental follow-up, build a calibration set: run FEP+ predictions on a set of congeneric compounds where you have experimental solubility or binding data and track the prediction error to understand where the model is reliable for your specific chemical series and target class.
AI is sitting alongside you hereIdentify candidate materials compositions for a specific target property set (e.g., high thermal conductivity, low dielectric constant, target refractive index) using the Materials Project database and Citrine Informatics AI, querying DFT-computed property data across hundreds of thousands of known inorganic and organic crystal structures
Identify candidate materials compositions for a specific target property set (e.g., high thermal conductivity, low dielectric constant, target refractive index) using the Materials Project database and Citrine Informatics AI, querying DFT-computed property data across hundreds of thousands of known inorganic and organic crystal structures; filtering candidates by synthesizability and commercial precursor availability; using Citrine active-learning models trained on published experimental data to predict properties for candidates not yet in the database; selecting a shortlist for experimental synthesis and characterization.[17],[8],[13]
Materials Project DFT calculations assume ideal crystalline structures at absolute zero: predictions for amorphous, nano-structured, or thin-film forms of the same compound can differ substantially from bulk crystal values. Before committing to synthesis of a Materials Project hit, check whether the target application environment (high temperature, moisture, high electric field) is represented in the existing experimental data the Citrine model was trained on. Property prediction is reliable within the chemical space the training data covers; extrapolation to genuinely novel chemistries should be treated as a hypothesis to test, not a confirmed design.
Where chemists go next
Natural next steps for someone with your foundation: not exits, evolutions.
- Natural Sciences Managers
- US median pay
- $167,220 (May 2025)
- BLS outlook 2025-35
- +8.2%
- Data Scientists
- US median pay
- $120,230 (May 2025)
- BLS outlook 2025-35
- +34.6%
- Materials ScientistsNo timeline for this role yet
What each move takes
Natural Sciences Managers
Chemists who develop cross-functional research leadership skills (directing synthesis teams, managing R&D programs, and bridging between chemistry, biology, and engineering stakeholders in pharma or materials science organizations) transition naturally into Natural Sciences Manager roles. This path is especially well-timed as AI tools are reshaping chemistry R&D workflows: deciding which AI platforms to invest in (IBM RXN, Schrödinger, Citrine), setting standards for AI-assisted synthesis route selection, and managing the transition of chemistry teams from manual-first to AI-augmented workflows all require managers with both bench credibility and operational scope. BLS projects +8% growth through 2034.
- · Research program management: portfolio prioritization across synthesis campaigns, external collaboration governance (CROs, CDMOs), milestone-based go/no-go decision frameworks for drug or materials candidates
- · AI tool strategy for chemistry R&D: evaluating and deploying AI synthesis planning, virtual screening, and active-learning DOE platforms; setting organizational review standards for AI-generated route recommendations and property predictions
- · Intellectual property management: patent portfolio strategy for chemical inventions, inventor team coordination, and FTO (freedom-to-operate) analysis oversight with legal counsel
- · Cross-functional scientific leadership: coordinating chemists, biologists, engineers, and analytical scientists across multi-year discovery programs in pharma, materials, or agrochemical R&D
- · Executive communication: translating synthesis risk, timelines, IP status, and AI tool ROI into portfolio-level business impact for non-technical leadership and investment committees
How has the work of chemists changed since 1720?
The tools that defined the work, one line per era. Select an era to see how it reshaped the work.
Fire, balance, and glass: the classical laboratory (furnace-centered design)
The 18th-century chemist worked in a furnace-centered laboratory descended from alchemical workshops: ceramic crucibles, retorts, and alembics for distillation; balance and weights for quantitative measurement; simple acids (sulfuric, nitric, hydrochloric) produced from vitriol and saltpeter. The Mettler analytical balance, achieving milligram precision, and Scheele's isolation of chlorine, manganese, and tartaric acid demonstrated what careful wet chemistry could do without any instrument beyond glass and fire. Lavoisier's greatest innovation was methodological: he demanded precise before-and-after mass measurements for every reaction, turning chemistry from a qualitative art into a quantitative science. No significant labor displacement occurred in this era -- the chemist's work was inherently artisanal and irreplaceable.
Bunsen burner bench laboratory and spectroscopic identification (Liebig-era design)
Robert Bunsen and Gustav Kirchhoff developed emission spectroscopy in 1859 at Heidelberg, showing each element emits a unique spectral fingerprint. Coupled with the gas burner that Bunsen and Peter Desaga perfected (producing a controllable, soot-free flame), this gave chemists a fundamentally new identification tool that could detect trace elements in complex mixtures far faster than wet gravimetric methods. Justus von Liebig's Giessen laboratory, opened around 1826, established the pedagogical model of bench-based systematic synthesis and analysis that spread to every major university by 1870. By 1870 the laboratory design had stabilized: central bench, fume hood, reagent bottles, gas line, and a small spectroscope. This infrastructure remained essentially standard until the mid-20th century. The spectroscope sharply reduced the time required for elemental identification and enabled new synthetic programs (discovering caesium and rubidium in 1860-61, for example), but it augmented rather than displaced the trained chemist.
Instrumental analysis revolution: IR, UV-Vis, GC, NMR, and mass spectrometry
Between 1950 and 1970, a cascade of new instruments transformed analytical chemistry almost beyond recognition. Gas chromatography (invented by Martin and James in 1952, Nobel Prize 1952) gave chemists their first routine tool for separating and quantifying volatile mixtures that had previously required days of fractional distillation. The first commercial GC-MS debuted in 1965; IR and UV-Vis spectrophotometers became standard bench instruments in most chemistry departments by the mid-1950s (Perkin-Elmer had been manufacturing IR instruments since 1940). Nuclear magnetic resonance spectrometers entered chemistry departments starting in the late 1950s and became the primary structure-determination tool for organic chemists through the 1960s. These instruments accelerated structure determination from weeks of classical degradation chemistry to hours of spectral interpretation, releasing chemists from the most time-consuming routine identification work and allowing smaller teams to cover more chemical territory. The net effect on employment was expansionary: faster structure confirmation enabled faster synthesis programs, and faster programs meant more chemists could work productively in parallel.
Effect on the workEach major instrument (GC, NMR, IR, MS) displaced specific manual wet-chemistry workflows but opened new research capability that absorbed the freed time. The 1960s-1970s pharmaceutical industry used the new speed of spectroscopic structure confirmation to accelerate drug discovery campaigns dramatically, growing the total chemist workforce throughout the period rather than shrinking it.
HPLC autosamplers, computerized data systems, and laboratory robotics
The 1980s brought computational data-reduction to the analytical chemistry bench. HPLC (high-performance liquid chromatography) autosamplers allowed a single analytical chemist to queue up many samples overnight that previously would have required manual injections over multiple days. Computerized data acquisition systems -- replacing chart recorders with workstations running chromatography software -- allowed results to be compared, integrated, and archived electronically. Laboratory robotics systems from Zymark could perform the entire sample preparation and NMR tube insertion sequence automatically. Zymark's 1980s systems reduced hands-on bench time for routine analytical workflows for the specific tasks they automated. The net effect was a radical reorganization of the analytical chemistry department: fewer technician hours per batch, faster turnaround for synthesis programs, and a shift in the analytical chemist's role from hands-on sample handling toward interpretation, method development, and data oversight.
Effect on the workLaboratory automation in the 1980s did reduce the number of chemical technicians and junior analytical chemists needed per sample batch, particularly in pharmaceutical QC. It did not reduce the total demand for bench chemists -- it redirected demand toward method development, instrument qualification, and data interpretation, roles requiring more chemical expertise, not less.
Molecular modeling and computational chemistry: Gaussian, HyperChem, DFT, and virtual screening
Gaussian (originating from John Pople's group at Carnegie Mellon and released commercially from 1970, with PC-accessible versions from the late 1980s) and HyperChem (1992) brought quantum mechanical structure and energy calculations to the individual chemist's desktop. Through the 1990s, density functional theory (DFT) became practical on workstations fast enough to give useful energy and geometry predictions for drug-sized molecules. Medicinal and materials chemists could now generate and evaluate virtual molecular structures before committing to synthesis. High-throughput virtual screening -- evaluating millions of candidate molecules by predicted binding affinity before purchasing or synthesizing any of them -- emerged as a standard early-stage tool in pharmaceutical discovery by the mid-2000s. The Schrödinger Glide docking suite (commercial from 2001) became the industry standard for structure-based virtual screening. This shifted the early phase of a drug discovery campaign from physical assay of compound libraries toward computational pre-filtering, dramatically increasing the hit rate of the molecules that reached the bench.
Effect on the workVirtual screening did not eliminate the medicinal chemist; it shifted the bottleneck from "synthesize and test everything" to "synthesize and test the AI-predicted winners." Chemistry departments grew a new specialty -- computational chemist, cheminformatics scientist -- without contracting the synthetic side, because faster design cycles required more synthesis throughput, not less.
Electronic lab notebooks (ELN), cloud data platforms, and high-throughput screening automation
The mid-2010s brought the digitization of the chemistry lab itself. Electronic lab notebooks -- most prominently Benchling (founded 2012, reaching 70% of top-20 pharma by 2025) -- replaced paper notebooks with searchable, auditable, structured data records. This was not merely administrative convenience: structured ELN data made synthesis records machine-queryable for the first time, enabling a chemistry department to search its entire experimental history for precedents, reagent usage patterns, and yield statistics that previously lived in unindexed paper notebooks on shelves. Simultaneously, acoustic dispensing systems (Echo liquid handlers), automated synthesis platforms, and plate-reader arrays brought higher throughput to medicinal and materials chemistry workflows. The volume of compounds a team could characterize per week expanded dramatically without a proportional increase in headcount. The regulatory significance was also important: 21 CFR Part 11 compliant ELN records dramatically simplified FDA inspection preparation for pharmaceutical laboratories.
AI-native chemistry: IBM RXN retrosynthesis, AlphaFold 3, Schrodinger FEP+, Citrine active-learning DOE
The 2022-2026 wave of AI tools represents the most concentrated transformation of the chemist's workflow since the introduction of NMR. IBM RXN for Chemistry (trained on millions of reactions, commercially available since 2018 and widely adopted in pharma R&D by 2022) generates multi-step retrosynthetic routes from a target molecule in minutes -- work that previously occupied a medicinal chemist for a week of SciFinder searches. AlphaFold 3 (DeepMind, May 2024) predicts protein-ligand-DNA co-complex structures with atomic-level accuracy, giving structural biologists and medicinal chemists structural hypotheses that previously required months of X-ray crystallography campaigns. Schrödinger FEP+ free energy perturbation provides quantitative binding and solubility predictions that compress hit-to-lead timelines significantly. Citrine Informatics active-learning DOE reduces the number of experiments required to navigate multi-dimensional materials composition spaces by 3-10x. Mestrelab Mnova AI automates NMR peak assignment and structure verification for routine compound classes, reducing spectral processing time by 60-80%. Taken together, the AI-native chemist -- fluent in both bench technique and this toolstack -- completes synthesis campaigns faster than the pre-AI baseline, according to early ACS survey data. The role is augmenting at extraordinary speed, and demand is growing: BLS projects +5% through 2034, driven by pharma R&D expansion (ADCs, PROTACs, RNA therapeutics), battery materials, and semiconductor chemicals.
Effect on the workNo net employment contraction is projected. The AI tools are compressing cycle time within existing research programs, not eliminating the programs.
See the same long-arc view for your own profession.
Browse the directory by industry, or search by title or SOC code.
Browse all rolesChemists employment and pay by year
In other countries
The latest figure each country's statistics agency publishes for this job. Each uses its own occupation definition, survey basis and currency, so the numbers are not directly comparable with each other or with the US figures.
Canada (NOC 21101)
- Employment, 2020
- 16,325, Statistics Canada Census 2021 Official statistic Report an errorStatistics Canada Census of Population 2021: number of persons with employment income in NOC 21101 Chemists, Canada, reference year 2020. A recipients basis (anyone with employment income during the year), slightly broader than a point-in-time employed count. Statistics Canada Open Licence.
- Median pay, 2020
- C$72,500, Statistics Canada Census 2021 Official statistic Report an errorStatistics Canada Census of Population 2021 (Table 98-10-0586): median employment income for NOC 21101 Chemists, Canada, reference year 2020, full-year full-time workers (the basis comparable to the US OEWS full-time median). Statistics Canada Open Licence.
View all 30 years of cited US data, each linked to its source
| Year | US employment | Annual pay (median unless marked) | Source | Report |
|---|---|---|---|---|
| 1900 | 9,000 | n/a | Decennial Census 1940 Researched context | Report |
| 1920 | 28,000 | n/a | Decennial Census 1920 Researched context | Report |
| 1950 | 69,000 | n/a | Decennial Census 1950 Researched context | Report |
| 1960 | n/a | $8,200 | Est., University of Missouri Libraries Researched context | Report |
| 1980 | 87,000 | n/a | Est., BLS Monthly Labor Review Researched context | Report |
| 1982 | n/a | $31,000 | BLS historical bulletin 1982 Researched context | Report |
| 2000 | 82,320 | $50,080 | BLS OEWS 2000 Official statistic | Report |
| 2003 | 82,600 | $53,650 | BLS OEWS May 2003 Official statistic | Report |
| 2004 | 79,650 | $56,060 | BLS OEWS May 2004 Official statistic | Report |
| 2005 | 76,540 | $57,890 | BLS OEWS May 2005 Official statistic | Report |
| 2006 | 80,500 | $59,870 | BLS OEWS May 2006 Official statistic | Report |
| 2007 | 79,860 | $63,490 | BLS OEWS May 2007 Official statistic | Report |
| 2008 | 83,080 | $66,230 | BLS OEWS May 2008 Official statistic | Report |
| 2009 | 79,910 | $68,220 | BLS OEWS May 2009 Official statistic | Report |
| 2010 | 80,180 | $68,320 | BLS OEWS May 2010 Official statistic | Report |
| 2011 | 80,040 | $69,760 | BLS OEWS May 2011 Official statistic | Report |
| 2012 | 84,950 | $71,770 | BLS OEWS May 2012 Official statistic | Report |
| 2013 | 87,560 | $72,350 | BLS OEWS May 2013 Official statistic | Report |
| 2014 | 85,970 | $73,480 | BLS OEWS May 2014 Official statistic | Report |
| 2015 | 84,720 | $71,260 | BLS OEWS May 2015 Official statistic | Report |
| 2016 | 86,660 | $73,740 | BLS OEWS May 2016 Official statistic | Report |
| 2017 | 84,400 | $74,740 | BLS OEWS May 2017 Official statistic | Report |
| 2018 | 84,560 | $76,890 | BLS OEWS May 2018 Official statistic | Report |
| 2019 | 83,530 | $77,630 | BLS OEWS May 2019 Official statistic | Report |
| 2020 | 82,940 | $79,300 | BLS OEWS May 2020 Official statistic | Report |
| 2021 | 80,600 | $79,430 | BLS OEWS May 2021 Official statistic | Report |
| 2022 | 83,940 | $80,670 | BLS OEWS May 2022 Official statistic | Report |
| 2023 | 83,530 | $84,680 | BLS OEWS May 2023 Official statistic | Report |
| 2024 | 83,250 | $84,150 | BLS OEWS May 2024 (employment) Official statisticBLS OEWS May 2024 (pay) Official statistic | Report |
| 2025 | 82,770 | $91,240 | BLS OEWS May 2025 Official statistic | Report |
More in Science
- Medical Scientists, Except Epidemiologists
- Occupational Health and Safety Specialists
- Environmental Scientists and Specialists, Including Health
- Clinical and Counseling Psychologists
- Biological Technicians
- School Psychologists
- Chemical Technicians
- Urban and Regional Planners
- Environmental Science and Protection Technicians, Including Health
- Biochemists and Biophysicists